TriSalus Life Ownership
| TLSI Stock | 4.89 0.01 0.20% |
TriSalus Stock Ownership Analysis
About 50.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 1.1. TriSalus Life Sciences had not issued any dividends in recent years. To find out more about TriSalus Life Sciences contact MBA BSN at (888) 321-5212 or learn more at https://trisaluslifesci.com.Besides selling stocks to institutional investors, TriSalus Life also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different TriSalus Life's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align TriSalus Life's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
TriSalus Life Quarterly Liabilities And Stockholders Equity |
|
TriSalus Life Insider Trades History
About 50.0% of TriSalus Life Sciences are currently held by insiders. Unlike TriSalus Life's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against TriSalus Life's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of TriSalus Life's insider trades
TriSalus Life Sciences Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific TriSalus Life insiders, such as employees or executives, is commonly permitted as long as it does not rely on TriSalus Life's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases TriSalus Life insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
TriSalus Life Outstanding Bonds
TriSalus Life issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. TriSalus Life Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most TriSalus bonds can be classified according to their maturity, which is the date when TriSalus Life Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| TRTN 315 15 JUN 31 Corp BondUS89680YAC93 | View | |
| TRTN 205 15 APR 26 Corp BondUS89680YAA38 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| TGI 9 15 MAR 28 Corp BondUS896818AU56 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Currently Active Assets on Macroaxis
| JMIA | Jumia Technologies AG | |
| ICL | ICL Israel Chemicals | |
| ASUR | Asure Software | |
| VIOT | Viomi Technology ADR | |
| KFY | Korn Ferry |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TriSalus Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TriSalus Life. If investors know TriSalus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TriSalus Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.10) | Revenue Per Share | Quarterly Revenue Growth 0.42 | Return On Assets | Return On Equity |
The market value of TriSalus Life Sciences is measured differently than its book value, which is the value of TriSalus that is recorded on the company's balance sheet. Investors also form their own opinion of TriSalus Life's value that differs from its market value or its book value, called intrinsic value, which is TriSalus Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TriSalus Life's market value can be influenced by many factors that don't directly affect TriSalus Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TriSalus Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if TriSalus Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TriSalus Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.